ResearchMoz

Continuous Glucose Monitoring Market (Guardian Real Time, FreeStyle Navigator, Dexcom Seven Plus, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo CGM Systems and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Transparency Market Research
Published Date » 2014-03-06
No. Of Pages » 68
 This report studies the current scenario as well as the future market potential for continuous glucose monitoring systems (CGMS) globally. The market for these CGMS has been segmented by major devices/brands, namely, Guardian Real Time CGM System, FreeStyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, MiniMed Paradigm Revel/Veo System and others. The market for these systems has been extensively analyzed on the basis of factors such as their commercial launch, sales revenue, geographic presence, usage and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (CAGR)...
Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.2 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
2.2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rise in diabetic population globally
3.2.2 Rise in demand for point of care testing (POCT)
3.3 Market Restraints
3.3.1 Unfavourable reimbursement policies
3.3.2 Calibration issues
3.4 Market Opportunities
3.4.1 Development of continuous glucose monitoring devices based on non-invasive techniques
3.5 Porter’s Five Forces Analysis for the Global Continuous Glucose Monitoring Market
3.5.1 Bargaining power of suppliers
3.5.2 Bargaining power of buyers
3.5.3 Threat of substitutes
3.5.4 Threat of new entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography

Chapter 4 Continuous Glucose Monitoring (CGM) Market, by Device/Brand, 2011 – 2019 (USD Million)
4.1 Overview
4.1.1 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
4.2 Guardian Real Time CGM System
4.2.1 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
4.3 FreeStyle Navigator
4.3.1 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
4.4 Dexcom Seven Plus CGM System
4.4.1 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
4.5 Dexcom G4 Platinum
4.5.1 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
4.6 MiniMed Paradigm Revel/Veo System
4.6.1 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
4.7 Others
4.7.1 Global Other CGM Systems Market, 2011 – 2019 (USD Million)

Chapter 5 Global Continuous Glucose MonitoringMarket Revenue, by Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Global Continuous Glucose MonitoringMarket Revenue, by Geography, 2011 - 2019 (USD Million)
5.1.2 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World (RoW) Continuous Glucose Monitoring Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Market Share Analysis by Key Players: Global Continuous Glucose Monitoring Market
6.1.1 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Focus on emerging economies of Asia-Pacific, Latin America, Middle East and Africa
7.2 Investing in research and development of technologically advanced products with added benefits
7.3 Emphasis on price control

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Bayer AG
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.5 Recent Developments
8.3 Dexcom, Inc.
8.3.1 Company overview
8.3.2 Financial overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 GlySens Incorporated
8.4.1 Company overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.5 Insulet Corporation
8.5.1 Company overview
8.5.2 Financial overview
8.5.3 Product portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Medtronic, Inc.
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Development
8.7 Nova Biomedical Corporation
8.7.1 Company overview
8.7.2 Product portfolio
8.7.3 Business Strategies
8.7.4 Recent Developments
8.8 Senseonics, Incorporated
8.8.1 Company overview
8.8.2 Product portfolio
8.8.3 Business Strategies
8.8.4 Recent Developments

List of Tables


TABLE 1 Market Snapshot: Global Continuous Glucose Monitoring Market (2012 & 2019)
TABLE 2 Number of People with Diabetes (20-79 years), by Country/Territory, 2013 (Millions)
TABLE 3 Global Continuous Glucose Monitoring Market, by Device/Brand, 2011 – 2019 (USD Million)
TABLE 4 Global Continuous Glucose MonitoringMarket Revenue, by Geography, 2011 – 2019 (USD Million)

List of Figures


FIG. 1 Continuous Glucose Monitoring: Market Segmentation
FIG. 2 Global Continuous Glucose Monitoring Market, by Device/Brand, 2012 (USD Million)
FIG. 3 Porter’s Five Force Analysis: Global Continuous Glucose Monitoring Market
FIG. 4 Market Attractiveness Analysis: Global Continuous Glucose Monitoring Market, by Geography
FIG. 5 Global Guardian Real Time CGM System Market, 2011 – 2019 (USD Million)
FIG. 6 Global FreeStyle Navigator Market, 2011 – 2019 (USD Million)
FIG. 7 Global Dexcom Seven Plus CGM System Market, 2011 – 2019 (USD Million)
FIG. 8 Global Dexcom G4 Platinum Market, 2011 – 2019 (USD Million)
FIG. 9 Global MiniMed Paradigm Revel/Veo System Market, 2011 – 2019 (USD Million)
FIG. 10 Global Other CGM Systems Market, 2011 – 2019 (USD Million)
FIG. 11 Comparative Analysis: Global Continuous Glucose Monitoring Market Revenue, by Geography, 2012 & 2019 (Value %)
FIG. 12 North America Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Europe Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Asia-Pacific Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 RoW Continuous Glucose Monitoring Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Continuous Glucose Monitoring Market Share Analysis, by Key Players, 2012 (%)
FIG. 17 Annual Revenue: Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 18 Annual Revenue: Bayer AG., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenue: Dexcom, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenue: Insulet Corporation, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenue: Medtronic, Inc., 2010 – 2012 (USD Million)

Upcoming Reports:

Anti Peptic Ulcer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
An anti-peptic ulcer drug is a class of drugs used for the treatment of most common ulcers in stomach and upper part of small intestine. These drugs act by decreasing the levels of gastric acidity or by enhancing the protection for mucosa. Major causes of peptic ulcer are Helicobacter pylori (H. pylori) infection or due to long-term use of drugs such as aspirin, ibuprofen and non-steroidal anti-inflammatory drugs (NSAIDs). Anti-peptic ulcer drugs market is classified based on: Drug class Proton pump inhibitor H2 receptor antagonist Gastric mucosal protective...
Cement Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Cement is a key building material which is used as a binder. Clay and limestone are key raw materials used in the manufacture of cement. Cement can also be used in mixture as a concrete and mortar. Mortar is formed by mixing cement with sand whereas concrete is formed by mixing cement, sand, fine aggregate and coarse aggregate. Mortar is used to bind blocks, stone and bricks into walls. Concrete is used in varied constructional purposes. One of the major drivers for cement market is steady and consistent growth in construction industry. Strong growth prospects of construction industry...
Energy Retrofits Market for Commercial and Public Buildings - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
The rising demand for energy and limited/inefficient storage systems are proving inadequate to satisfy the demand for industrial energy requirements. Researchers are aggressively and continuously working in order to develop and manufacture effective and efficient systems that will store and distribute the required amount of energy globally. Energy retrofits are the adjustment or addition to the existing energy consuming equipment that are utilized in commercial outlets and in buildings. The desire to reduce energy costs required to operate the industry is the primary driving...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Loss recorded due to heavy investments carried out by Amazon
Jul 25, 2014  
Amazon.com Inc has been investing in newer businesses like consumer electronics and digital content, due to which it has been running into losses for some time now. The loss recorded in the second quarter was by far the highest. In 2014, the stock prices have dropped by 10% with reduced investor confidence in the long term growth investments. The shares of this US based online retailer...
LG Electronics To Invest Huge Capital in R&D Project in South Korea
Jul 25, 2014  
LG Electronics Inc will invest USD 1.26 billion in the construction of a new research and development unit in South Korea’s capital city Seoul. The facility is said to be part of LG’s Science Park project. The 170,000 square meters site will be built in Magok, Seoul and work is expected to begin from August. Once the construction is complete and ready by 2020, the park will house...
Russian Consumer Protection Agency Seeks ban on Some McDonalds Products
Jul 25, 2014  
A lawsuit has been filed in a Moscow court by the Russian consumer protection agency to seek ban on some products from McDonald's Corp's burgers menu, along with its ice creams and shakes menu.  A regional branch of the agency has recently filed a lawsuit asking the court to declare a ban on some products due to some inappropriateness in physical-chemical parameters in the...
High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...